Beta Adrenergic Induced Pulmonary Arterial Vasodilation Following Long Term Hypoxia in Fetal and Adult Sheep

Abstract

Long term high altitude exposure is known to cause tissue hypoxia and exposure of fetuses as well as adults to rarefied environments increases morbidity and mortality. In particular, hypoxia can cause developmental abnormalities in the fetal pulmonary vasculature and contribute to pulmonary arterial hypertension in the adult. β2 adrenergic receptor (β‐AR) agonists are a major treatment for asthma, however far less is known about their role in pulmonary arterial function. Even still, previous evidence illustrates that β‐AR stimulation holds promise for the treatment of pulmonary arterial hypertension. Other evidence illustrates that β‐AR stimulation modulates the activity of Ca2+‐activated K+ channels (KCa), which are important mediators of pulmonary vasorelaxation. Dysregulation of KCa may contribute to chronic hypoxia induced pulmonary hypertension and β‐AR signaling may be involved in the process. In these studies we tested the hypothesis that β‐AR ‐ mediated pulmonary arterial vasodilation may be preserved following long term high altitude hypoxia due to dependency on KCa channels. This hypothesis was addressed in isolated pulmonary arteries from adult or fetal sheep that gestated at 700 meters (normoxic) or 3,801 meters for 110+ days (hypoxic). Myography was performed on pulmonary arterial rings to evaluate the vasorelaxation in response to the β‐AR agonist isoproterenol (ISO) and the methylxanthine phosphodiesterase inhibitor, IBMX. ISO‐mediated relaxation was preserved following hypoxia in fetal sheep and relaxation was greater in arteries from adult hypoxic animals relative to fetuses. Inhibition of BKCa with TEA blunted ISO‐mediated vasorelaxation in fetal normoxic and adult hypoxic arteries. IBMX caused a dose dependent relaxation in arteries from all groups and TEA did not influence this effect. Overall, these studies provide evidence that β‐AR stimulated pathways cause pulmonary arterial vasodilation, but with varying reliance on BKCa activation. Targeting β‐AR signaling pathways could therefore be therapeutically significant and functional alterations in the pathways may contribute to the development of disease.Support or Funding InformationThis material is based upon work supported by NIH HD‐069746, P01HD083132, and P20MD006988. MA and BP were Walter E Macpherson Medical Student Summer Research Fellows while AV was an Undergraduate Summer Research Fellow through the Center for Health Disparities and Molecular Mechanisms at Loma Linda University.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.